New guidelines aim treat brain tumors more effectively

August 10, 2017
Professor Geoff Pilkington. Credit: University of Portsmouth

A University of Portsmouth academic has helped to develop European guidelines to treat brain tumours more effectively.

Geoff Pilkington, Professor of Cellular and Molecular Neuro-oncology and one of the UK's leading brain tumour specialists, was one of only three UK academics who devised the European Association for Neuro-Oncology (EANO) guidelines on the diagnosis and of with astrocytic and oligodendroglial gliomas, including glioblastomas.

The guidelines provide guidance for diagnostic and management decisions, while limiting unnecessary treatments and costs. They are a resource for professionals involved in the management of with glioma, for patients and caregivers and for health-care providers in Europe.

The recommendations discuss prevention, early diagnosis and screening, histological and molecular diagnostics, therapy and follow-up. The authors have also integrated the results from recent clinical trials that have changed clinical practice.

Professor Pilkington, Head of the Brain Tumour Research Centre at the University of Portsmouth, said: "The implementation of this guideline requires multidisciplinary structures of care and defined processes of diagnosis and treatment. It focuses on pathological and radiological diagnostics and the main treatment methods of surgery, radiotherapy and pharmacotherapy.

"For example, the use of prognostic and diagnostic markers such as IDH mutations and MGMT methylation status, may aid in improved therapeutic planning with high grade malignancies."

The guidelines are based on the May 2016 WHO classification of tumours of the central nervous system and on scientific developments since the 2014 guideline.

Professor Pilkington added: "The new guidelines are timely, coming in the wake of the revised WHO classification of tumours of the central nervous system which adds molecular profiling to classical histopathological pattern recognition in order to potentially stratify individual sub-groups of patients to receive more personalised therapies. This, we hope, will lead to improved survival times and improved quality of life, post treatment."

Read the EANO guidelines here

Explore further: Preventing the development of brain tumours

Related Stories

Preventing the development of brain tumours

August 3, 2017
Researchers from the University of Portsmouth's Brain Tumour Research Centre of Excellence have identified molecules which are responsible for metastatic lung cancer cells binding to blood vessels in the brain.

Improving the survival rates of childhood brain tumours: Translating Discoveries

July 13, 2017
The future of children with brain tumours is very promising. To do nothing is to ignore the very real possibility of a treatment and cure. It is the time now to accelerate clinical and laboratory research in childhood brain ...

Guidelines developed for perinatal hematologic cancers

December 7, 2015
(HealthDay)—Consensus guidelines have been developed for clinical management of hematologic malignancies during the perinatal period, according to a special article published online Nov. 30 in the Journal of Clinical Oncology.

New recommendations for the diagnosis and treatment of adrenal incidentalomas

July 13, 2016
The appropriate clinical response to adrenal incidentaloma should depend on the likelihood of malignancy, according to new guidelines published today by the European Society of Endocrinology (ESE), in collaboration with the ...

AMP issues joint guideline to standardize interpretation and reporting of sequence variants in cancer

December 16, 2016
The Association for Molecular Pathology (AMP), the premier global, non-profit molecular diagnostics professional society, today published guideline recommendations for both clinical laboratory professionals and oncologists ...

ESMO releases new consensus guidelines on the management of metastatic colorectal cancer

July 6, 2016
ESMO, the leading European professional organisation for medical oncology, has released new consensus guidelines for the management of metastatic colorectal cancer that reflect an increasingly personalized approach to treatment, ...

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.